- Home
- DRRX vs NXPLW Comparison
DRRX vs NXPLW Comparison
Compare DRRX & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRRX
- NXPLW
- Stock Information
- Founded
- DRRX 1998
- NXPLW N/A
- Country
- DRRX United States
- NXPLW United States
- Employees
- DRRX N/A
- NXPLW 166
- Industry
- DRRX Biotechnology: Pharmaceutical Preparations
- NXPLW Telecommunications Equipment
- Sector
- DRRX Health Care
- NXPLW Telecommunications
- Exchange
- DRRX Nasdaq
- NXPLW Nasdaq
- Market Cap
- DRRX N/A
- NXPLW N/A
- IPO Year
- DRRX 2000
- NXPLW N/A
- Fundamental
- Price
- DRRX $0.70
- NXPLW $0.15
- Analyst Decision
- DRRX Hold
- NXPLW
- Analyst Count
- DRRX 1
- NXPLW 0
- Target Price
- DRRX N/A
- NXPLW N/A
- AVG Volume (30 Days)
- DRRX 54.0K
- NXPLW 6.4K
- Earning Date
- DRRX 05-12-2025
- NXPLW 03-31-2025
- Dividend Yield
- DRRX N/A
- NXPLW N/A
- EPS Growth
- DRRX N/A
- NXPLW N/A
- EPS
- DRRX N/A
- NXPLW N/A
- Revenue
- DRRX $2,031,000.00
- NXPLW $66,482,000.00
- Revenue This Year
- DRRX N/A
- NXPLW N/A
- Revenue Next Year
- DRRX $935.93
- NXPLW N/A
- P/E Ratio
- DRRX N/A
- NXPLW N/A
- Revenue Growth
- DRRX N/A
- NXPLW 179.89
- 52 Week Low
- DRRX $0.67
- NXPLW $0.25
- 52 Week High
- DRRX $1.88
- NXPLW $0.26
- Technical
- Relative Strength Index (RSI)
- DRRX 37.40
- NXPLW N/A
- Support Level
- DRRX $0.67
- NXPLW N/A
- Resistance Level
- DRRX $0.75
- NXPLW N/A
- Average True Range (ATR)
- DRRX 0.05
- NXPLW 0.00
- MACD
- DRRX -0.00
- NXPLW 0.00
- Stochastic Oscillator
- DRRX 20.00
- NXPLW 0.00
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.